References
- European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2019. Trend and developments. 2019 [accessed 2020 Mar 17]. Available from: http://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ESN_PDF.pdf
- European Monitoring Centre for Drugs and Drug Addiction and Europol. EU Drug Markets Report 2019. Luxembourg: Publications Office of the European Union; 2019.
- Smith K. Gender differences in primary substance of abuse across age groups. The CBHSQ Report: April 3, 2014. Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2014.
- United nations Office on Drugs and Crime. World Drug Report 2018. 2018 [accessed 2020 May 19]. Available from: https://www.unodc.org/wdr2018/
- de Españade Sanidad GM. Consumo y Bienestar Social. Encuesta sobre alcohol y drogas en España. (EDADES), 1995-2017. [accessed 2020 May 19]. Available from: https://pnsd.sanidad.gob.es/profesionales/sistemasInformacion/sistemaInformacion/pdf/EDADES_2017_Informe.pdf
- LavrakasPJ.Encyclopedia of survey research methods. Thousand Oaks (CA): SAGE Publisher; 2008.
- KingMF, BrunerGC. Social desirability bias: a neglected aspect of validity testing. Psychol Mark. 2000;17:79–103.
- MiróÒ, GaliciaM. About the sources of knowledge of drug use and its consequences. Rev Esp Salud Publica. 2019; 90:e1–e3.
- Burillo-PutzeG, Matos CastroS. Emergency departments as observatories: a good view of street use and its clinical consequences. Emergencias. 2018;30:377–379.
- GaliciaM. Acute adverse effects of synthetic drugs: beginning to understand the magnitude of the problem in Spain. Emergencias. 2020;32:7–8.
- HeyerdahlF, HovdaKE, GiraudonI, et al. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Clin Toxicol. 2014;52:1005–1012.
- WoodDM, HeyerdahlF, YatesCB, et al. The European Drug Emergencies Network (Euro-DEN). Clin Toxicol. 2014;52:239–241.
- MiróO, YatesC, DinesAM, et al. Emergencies related to recreational drug abuse in Spain comparedto emergencies attended in 3 European areas. Emergencias. 2018; 30:384–394.
- GaliciaM, DarganPI, DinesAM, et al., Euro-DEN Plus Research Group. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication. Toxicol Lett. 2019;314:37–42.
- WolfeCE, WoodDM, DinesA, et al., Euro-DEN Research Group. Seizures as a complication of recreational drug use: analysis of the Euro-DEN Plus data-set. Neurotoxicology. 2019;73:183–187.
- MiróÒ, DarganPI, WoodDM, et al., Euro-DEN Plus Research Group. Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases. Clin Toxicol. 2019;57:718–726.
- LyphoutC, YatesC, MargolinZR, et al., Euro-DEN Research Group. Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data. Eur J Clin Pharmacol. 2019;75:77–85.
- YamamotoT, DarganPI, DinesA, et al., Euro-DEN Research Group. Concurrent use of benzodiazepine by heroin users-what are the prevalence and the risks associated with this pattern of use?J Med Toxicol. 2019;15:4–11.
- MiróÒ, GaliciaM, DarganP, et al. Intoxication by gamma hydroxybutyrate and related analogues: clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicol Lett. 2017; 277:84–91.
- VallersnesOM, DinesAM, WoodDM, et al., Euro-DEN Research Group. Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry. 2016;16:293.
- DegenhardtL, BharatC, GlantzMD, et al., for the WHO World Mental Health Survey Collaborators. Association of cohort and individual substance use with risk of transitioning to drug use, drug use disorder, and remission from disorder: findings from the world mental health surveys. JAMA Psychiatry. 2019;76:708–720.
- BestD, GowJ, KnoxT, et al. Mapping the recovery stories of drinkers and drug users in Glasgow: quality of life and its associations with measures of recovery capital. Drug Alcohol Rev. 2012;31:334–341.
- Fernández AlonsoC, Quintela JorgeO, Ayuso TejedorS, et al. Acute intoxication by new recreational drugs in probable cases of opportunistic and/or mixed chemical submission and chemsex in emergency department patients infected with human immunodeficiency virus. Emergencias. 2019;31:289–290.
- González Del CastilloJ, Burillo-PutzeG, CabelloA, et al. Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: a consensus statement of the Spanish Society of Emergency Medicine (SEMES). Emergencias. 2020;32:416–426.
- RademakerM. Do women have more adverse drug reactions?Am J Clin Dermatol. 2001;2:349–351.
- AndersonGD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008; 83:1–10.
- VallersnesOM, JacobsenD, EkebergO, et al. Patients presenting with acute poisoning to an outpatient emergency clinic: a one-year observational study in Oslo, Norway. BMC Emerg Med. 2015;15:18.
- LiakoniE, YatesC, DinesAM, et al. Acute recreational drug toxicity: comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. Medicine. 2018;97:e9784.
- VallersnesOM, PersettPS, ØiestadEL, et al. Underestimated impact of novel psychoactive substances: Laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clin Toxicol. 2017;55:636–644.
- HeyerdahlF, HovdaKE, BjornaasMA, et al. Clinical assessment compared to laboratory screening in acutely poisoned patients. Hum Exp Toxicol. 2008;27:73–79.
- DelásJ, MorcilloS. C. Emergences related to recreational drug abuse: the role of medically supervised drug consumption rooms. Emergencias. 2019; 31:219–220.